Lamotrigine Tablet
Product Images NDC 63629-4697

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 63629-4697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1

A Kaplan-Meier curve graph showing failure probability (%) over weeks (0 to 100) for Lamotrigine compared to placebo. The graph includes censored data points and displays the failure probability as increasing over time, with Lamotrigine exhibiting a consistently lower failure probability than placebo throughout the study duration.*

FDA Label Image

Figure2

A line graph comparing failure probability (%) over weeks between Lamotrigine and Placebo groups. The x-axis shows time in weeks up to 80, and the y-axis shows failure probability from 0 to 100%. Two lines represent Placebo and Lamotrigine, with censored data points marked. Placebo shows higher failure probability over time than Lamotrigine.*

FDA Label Image

Chemical Structure (Lamotriginestructrue)

Chemical structure diagram of lamotrigine, showing a triazine ring bonded to a chlorinated phenyl group and multiple amino groups, corresponding to the active ingredient lamotrigine.*

FDA Label Image

Lbl636294697

Lamotrigine 150 mg tablet label for oral use by Bryant Ranch Prepack, packaged in Burbank, CA. The label includes a comparison to Lamictal 150 mg tablets by Jubilant Cadista Pharma Inc. It indicates a quantity of 60 tablets, storage instructions at 20°-25°C (68°-77°F), and a lot number (1523487). The NDC displayed is 63629-4697-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.